98%
921
2 minutes
20
Lumpy skin disease virus (LSDV) is a rapidly emerging pathogen in Asia, including China. Genetic manipulation of the LSDV is essential for the elucidation of the pathogenic mechanism and biological function of the LSDV-encoded protein. In this study, we established a platform for the Cre-loxP recombination system under a modified early-late H5 promoter of the VACV for quick construction of the recombinant LSDV virus. The recombinant virus, LSDV-EGFP-ΔTK, was purified and obtained using serial limited dilution and picking the single cells methods. Using the lentiviral package system, a Cre recombinase enzyme stable expression MDBK cell line was established to supply the Cre recombinase for the reporter gene excision. A genetically stable, safe TK gene-deleted LSDV (LSDV-ΔTK) was constructed using homologous recombination and the Cre-loxP system. It was purified using limited dilution in the MDBK-Cre cell line. Establishing the Cre-loxP recombination system will enable sequential deletion of the interested genes from the LSDV genome and genetic manipulation of the LSDV genome, providing technical support and a platform for developing the attenuated LSDV vaccine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vetmic.2024.110122 | DOI Listing |
Nucleic Acids Res
August 2025
Wuhu Hospital, Health Science Center, East China Normal University, Wuhu 241001, China.
The Cre-loxP recombination system enables precise genome engineering; however, existing photoactivatable Cre tools suffer from several limitations, including low DNA recombination efficiency, background activation, slow activation kinetics, and poor tissue penetration. Here, we present REDMAPCre, a red-light-controlled split-Cre system based on the ΔPhyA/FHY1 interaction. REDMAPCre enables rapid activation (1-s illumination) and achieves an 85-fold increase in reporter expression over background levels.
View Article and Find Full Text PDFGenesis
August 2025
Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, USA.
Tissue-specific gene manipulation using Cre/loxP or Flp/frt recombination systems is a cornerstone of genetically engineered mouse models. In this study, we aim to develop a novel hepatocyte-specific, tamoxifen-inducible Flp mouse line. BAC (bacterial artificial chromosome)-Alb(albumin)-FlpER2(estrogen receptor ligan binding domain) was developed by inserting IRES-FlpER2 cDNA between the translation stop codon and 3'-UTR of the mouse albumin gene in a bacterial artificial chromosome.
View Article and Find Full Text PDFPlacenta
August 2025
Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Af
Objective: The placenta plays a critical role in fetal development, yet placenta-specific gene manipulation remains a challenge due to widespread gene expression across maternal and embryonic tissues. Here, we describe the generation and characterization of Cyp19a1-Cre-EGFP transgenic mice, a novel Cre-loxP model for placenta-specific gene recombination.
Methods: A Cyp19a1-Cre-EGFP construct was generated using the Cyp19a1 promoter, driving Cre recombinase expression with an enhanced green fluorescent protein (EGFP) reporter.
J Immunother Cancer
June 2025
Department of Dermatology, The First Affiliated Hospital, Anhui, Medical University, Hefei, Anhui, China
Background: A key aspect of tumor biology is the involvement of cancer-associated fibroblasts (CAFs) in shaping the immunosuppressive microenvironment. However, the dynamic and complex key roles of CAFs in the melanoma immune microenvironment have not been elucidated.
Methods: The CAFs landscape in melanoma was characterized using single-cell RNA-seq and spatial transcriptomics.
G3 (Bethesda)
August 2025
Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD 20892, USA.
The Cre-loxP system is a powerful tool for spatial and temporal genetic manipulations. However, the system is prone to several limitations and caveats with respect to variable expression and recombination in unintended cell types. Using one of the most widely used astrocyte Cre lines, hGFAP-creERT2 ((GFAP-cre/ERT2)505Fmv/J), we found that parental origin of the hGFAP-creERT2 transgene is a determinant of recombination efficiency.
View Article and Find Full Text PDF